If all goes according to the current schedule, on Friday, Dec. 19, 2014 ExoMed-3 will launch to the International Space Station aboard a SpaceX rocket.
will analyze the regeneration mechanisms of planarian flatworms in the microgravity environment (and absence of a geomagnetic field) of space. This experiment is a critical step in a specific regenerative medicine research and commercial pathway being pursued by the parties. Once returned (alive) to Earth mid-January, the flatworms’ regeneration patterns will be analyzed via morphological molecular genetic methods.
The mission will also feature the use of Google Glass to record astronaut interaction with Kentucky Space payloads. Transportation will be handled by FedEx Space Solutions.
Exomedicine is defined as the research and development of medical solutions in the microgravity environment of space.
Mission contact information may be found in the linked press release.